John Townsend
2021
In 2021, John Townsend earned a total compensation of $383.1K as Chief Financial Officer at Unicycive Therapeutics, a 864% increase compared to previous year.
Compensation breakdown
| Option Awards | $185,253 |
|---|---|
| Salary | $91,667 |
| Other | $106,197 |
| Total | $383,117 |
Townsend received $185.3K in option awards, accounting for 48% of the total pay in 2021.
Townsend also received $91.7K in salary and $106.2K in other compensation.
Rankings
In 2021, John Townsend's compensation ranked 11,244th out of 12,415 executives tracked by ExecPay. In other words, Townsend earned more than 9.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,244 out of 12,415 | 9th |
Division Manufacturing | 4,969 out of 5,508 | 10th |
Major group Chemicals And Allied Products | 2,207 out of 2,378 | 7th |
Industry group Drugs | 1,963 out of 2,099 | 7th |
Industry Pharmaceutical Preparations | 1,455 out of 1,549 | 6th |
Source: SEC filing on April 19, 2022.
Townsend's colleagues
We found two more compensation records of executives who worked with John Townsend at Unicycive Therapeutics in 2021.